Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pandemic H1N1 vaccine incidence and immunogenicity study in healthy adults
NL-OMON35537Phase 4Active, not recruiting
- Sponsor
- Registratie en Medische Unit
- Start
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated), ARCT-2138 in Influenza A infection, influenza, sponsored by Registratie en Medische Unit. Started Oct 2009; status: active, not recruiting.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)ARCT-2138
03
Conditions
Influenza A infectioninfluenza
Beyond the preview
Go deeper on NL-OMON35537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35537.